#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema multiforme Proteus syndrome Deafness neurosensory Krabbe's disease Glycogen storage disease type V Mantle cell lymphoma stage II Monogenic diabetes Immunodeficiency congenital Hereditary neuropathic amyloidosis Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Precursor T-lymphoblastic lymphoma/leukaemia recurrent Dilated cardiomyopathy Retinopathy of prematurity Encephalopathy neonatal Progressive familial intrahepatic cholestasis More trials…

    Learn about Rare Diseases

    Propionic acidaemia – Trials in Disease Gastrointestinal stromal tumour Friedreich’s ataxia – Life with Disease Familial haemophagocytic lymphohistiocytosis – Treatment Congenital nephrogenic diabetes insipidus – Basic Information Metachromatic leukodystrophy – Diagnostics Pelizaeus-Merzbacher disease – Trials in Disease Lymphangioma – Life with Disease Aicardi-Goutieres syndrome MELAS syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bms-986408 Dapagliflozin Cedazuridine Resiniferatoxin Citric Acid Monohydrate HUPERZINE A Edoxaban Morf-057 Censavudine MAGNESIUM ACETATE TETRAHYDRATE Bay 3018250 Rifabutin AZD4512 Agomelatine Filgrastim Gozetotide VORMATRIGINE Ly3454738 Anthoxanthum Odoratum Teprotumumab More therapies…

    Learn about Your Condition

    Appendicitis perforated Cholangiosarcoma Skin papilloma Diphtheria Hypervolaemia Cerebral palsy Binge eating Laparotomy Skin candida Pigmentary glaucoma Deafness bilateral Alveolar rhabdomyosarcoma Microscopic polyangiitis Angiopathy Glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz…

Fejer Varmegyei Szent Gyoergy Egyetemi Oktato Korhaz

Seregelyesi Ut 3, Szekesfehervar, 8000, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Bemcentinib
    • Carboplatin
    • Pembrolizumab
    France Greece Hungary Italy Poland Spain

  • Study of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    Austria Belgium France Germany Hungary Italy +3

  • Study on the Effects of FDY-5301 for Patients with Anterior ST-Elevation Myocardial Infarction (Heart Attack)

    Not recruiting

    3 1
    Investigated Drugs:
    • Sodium Iodide
    Czechia Germany Hungary Italy The Netherlands Poland +3

  • Study Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute haemorrhagic ulcerative colitis
    Investigated Drugs:
    • Sodium Chloride
    • Vedolizumab
    Bulgaria Croatia Czechia Greece Hungary Italy +5

  • Study on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Tamuzimod Acetate
    Bulgaria Czechia Germany Hungary Italy Lithuania +2

  • Study on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Etrasimod Arginine
    Belgium Bulgaria Czechia Estonia France Germany +8

  • Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Volrustomig
    • Carboplatin
    • Infliximab
    Austria Belgium Czechia France Germany Hungary +5

  • Study on Bepirovirsen for Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3

  • Study Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Ceralasertib
    • Docetaxel
    • Durvalumab
    Belgium France Germany Hungary Ireland Italy +4

  • Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Domvanalimab
    • Durvalumab
    • Infliximab
    Belgium France Germany Greece Hungary Italy +4
Previous Page
1 … 3 4 5 6 7 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!